Julia E. Tubert

Statistics

Publications

Citations

1.2K

H-Index

Active since

2019

Affiliations

Moderna Therapeutics (United States)(Current)

Kaiser Permanente

University of Alabama at Birmingham

AstraZeneca (United States)

University of California, Los Angeles

Julia E. Tubert is an author at Moderna Therapeutics (United States) specializing in veterinary medicine, sars-cov-2 infection, and infectious diseases.

ORCID

Publications per year

2019–2024

Publications

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

Hung Fu Tseng, Bradley K. Ackerson, Yi Luo et al. · Nature Medicine · 2022 · 556 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

Hung Fu Tseng, Bradley K. Ackerson, Katia Bruxvoort et al. · Nature Communications · 2023 · 109 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants

Hung Fu Tseng, Bradley K. Ackerson, Yi Luo et al. · medRxiv · 2022 · 105 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study

Katia Bruxvoort, Lina S. Sy, Lei Qian et al. · The Lancet Regional Health - Americas · 2021 · 87 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States

Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy et al. · Nature Communications · 2023 · 67 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 17